YIKON GENOMICS
Yikon Genomics is a leading solution-based single cell sequencing company. Currently based on the patented MALBAC® technology from Harvard University, Yikon provides complete solutions in the fields of reproductive health and cancer diagnostics with liquid tumor biopsy. The MALBAC-PGS™ and MALBAC-PGD™ solutions offer the most accurate and comprehensive embryo testing results for physicians to choose the best embryos with balanced chromosomal copy numbers,without inheriting the known disease-associated alleles. The MALBAC-PGS™ and MALBAC-PGD™ solutions have helped thousands of couples to achieve successful pregnancies. Yikon will continue to interpret the code of life and bring people the hope and joy of life.
YIKON GENOMICS
Industry:
Biotechnology Genetics
Founded:
2012-01-01
Address:
Minhang, Shanghai, China
Country:
China
Website Url:
http://www.yikongenomics.com
Total Employee:
11+
Status:
Active
Contact:
0086-400-9123-918
Email Addresses:
[email protected]
Total Funding:
69.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Font Awesome Domain Not Resolving Mobile Non Scaleable Content Nginx DigiCert SSL UNPKG
Similar Organizations
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Oriza Holdings
Oriza Holdings investment in Series D - Yikon Genomics
Sinopharm Capital
Sinopharm Capital investment in Series D - Yikon Genomics
YF Capital
YF Capital investment in Series D - Yikon Genomics
General Technology Venture Capital
General Technology Venture Capital investment in Series D - Yikon Genomics
Zhongjin Qide
Zhongjin Qide investment in Series D - Yikon Genomics
Wuhan Zhongyuan Huadian Science & Technology
Wuhan Zhongyuan Huadian Science & Technology investment in Series C - Yikon Genomics
KingMed Diagnostics
KingMed Diagnostics investment in Series C - Yikon Genomics
Guangzhou Yuexiu Industrial Investment Fund
Guangzhou Yuexiu Industrial Investment Fund investment in Series C - Yikon Genomics
Yuexiu Group
Yuexiu Group investment in Series C - Yikon Genomics
Official Site Inspections
http://www.yikongenomics.com Semrush global rank: 8.4 M Semrush visits lastest month: 319
- Host name: 47.98.63.122
- IP address: 47.98.63.122
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
